Gene and Cell Therapy Strategist
Betsy Foss-Campbell, MA, Gene and Cell Therapy Strategist, is a seasoned strategy and policy advocate who has been at the forefront of driving and advancing novel regulatory pathways for the cutting edge field of regenerative medicine, specifically gene and cell therapy. She has a unique ability to identify and define challenges in the field, communicate the science, and work with diverse interests to craft policies, alliances and implement win-win strategies that help relevant government entities from FDA to NIH to Capitol Hill best serve the needs of patients and innovators.
Ms. Foss-Campbell has over 28 years of professional experience spanning varied areas. She has served in senior nonprofit management roles for the past eight years, including Executive Director-level leadership, with an emphasis in scientific association management.
Most recently she was the Director of Policy and Advocacy at the American Society of Gene and Cell Therapy, where she promoted the development of, and patient access to, transformative treatments. While at ASGCT, Ms. Foss-Campbell developed multiple new initiatives, including an annual FDA liaison meeting, an annual Policy Summit tackling hot policy topics, and a patient education program. She also oversaw global outreach efforts and helped launch diversity and inclusion awards. Her work has connected her with thought leaders at numerous biotechnology and pharmaceutical companies, patient advocacy organizations, and other professional societies and trade organizations in the gene and cell therapy, rare disease, and oncology spaces.
Ms. Foss-Campbell’s experiences include social issue/policy advocacy and 15 years of direct healthcare service, treating individuals with upper extremity trauma at an academic medical center.
She received master’s degrees in political science and communication from Marquette University and a BS in occupational therapy from the University of Wisconsin.